Ye Weiguo 4
4 · GYRE THERAPEUTICS, INC. · Filed May 14, 2025
Insider Transaction Report
Form 4
Ye Weiguo
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2025-04-01$0.75/sh+50,000$37,500→ 700,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-04-01−50,000→ 965,115 totalExercise: $0.75Exp: 2030-10-31→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]These options are vested in full.